Neuroscience

Confronting the side effects of a common anti-cancer treatment

Results of a new study by neuroscientists at the University of Massachusetts Amherst and the University of Toronto suggest that a new treatment approach is needed—and how this may be possible—to address adverse effects ...

Obstetrics & gynaecology

Letrozole may help women with PCOS become pregnant

The drug letrozole results in higher birth rates in women with polycystic ovary syndrome (PCOS) than the current preferred infertility treatment drug, according to a nationwide study led by Penn State College of Medicine ...

Oncology & Cancer

Drug prevents bone loss side effects of breast cancer medication

A new study has found that an osteoporosis drug protects against the bone damaging side effects of certain breast cancer medications. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, ...

Oncology & Cancer

SABCS: PD 0332991 + letrozole studied in ER+ breast cancer

(HealthDay)—For women with estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer, the investigational agent PD 0332991 plus letrozole improves progression-free survival versus ...

Medications

Afinitor approved for advanced breast cancer

(HealthDay) -- Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food and Drug Administration ...

Oncology & Cancer

Pfizer breast cancer drug gets breakthrough label

Pfizer Inc. says its experimental pill for advanced, often deadly breast cancer has been designated as a breakthrough therapy by the Food and Drug Administration.

page 1 from 2